`
`Information for Vermont Prescribers of Prescription Drugs:
`
`Thalomid® (thalidomide) capsules
`
`* This list provides pricing information for oral products listed in the immunomodulatory agents
` classification.
`
`* This list does not imply that the products on this chart are interchangeable or have the same
` efficacy or safety. Please refer to each product's FDA-approved label and indication for further
` information.
`
` * The prices listed below are Average Wholesale Prices (AWP) as established and made available
` to the public by a third party publisher, or as calculated from data made available to the public
` by a third party publisher. The price paid by consumers may be higher or lower than the prices
` listed below. Information about AWP of these drugs is being provided to Vermont prescribers
` pursuant to Vermont law, to give you information about the relative prices of marketed drugs and
` other drugs in the same therapeutic class.
`
` * The prices listed here do not necessarily reflect price per dosage, price per course of
` treatment, or the cost effectiveness of all the products listed. For simplicity, only the smallest
` package sizes available for each product are included.
`
`
`
`Product Name
`
`Manufacturer
`
`NDC or UPC Pkg Size Per Pack
`
`Per Unit
`
`Marketed Product
`
`THALOMID CAP 50MG
`THALOMID CAP 100MG
`THALOMID CAP 150MG
`THALOMID CAP 200MG
`
`Other Products
`
`AUBAGIO TAB 7MG
`AUBAGIO TAB 14MG
`GILENYA CAP 0.5MG
`TECFIDERA CAP 120MG
`TECFIDERA CAP 240MG
`
`CELGENE CORP
`CELGENE CORP
`CELGENE CORP
`CELGENE CORP
`
`GENZYME
`GENZYME
`NOVARTIS
`BIOGEN IDEC
`BIOGEN IDEC
`
`59572020597
`59572021015
`59572021513
`59572022016
`
`58468021101
`58468021002
`00078060751
`64406000501
`64406000602
`
`10
`28
`28
`28
`
`28
`28
`28
`14
`60
`
`$2,255.83
`$9,320.90
`$9,966.34
`$10,612.20
`
`$6,093.88
`$6,093.88
`$6,530.96
`$1,528.80
`$6,552.00
`
`$225.58
`$332.89
`$355.94
`$379.01
`
`$217.64
`$217.64
`$233.25
`$109.20
`$109.20
`
`Medi-Span is the source of this information: July 1, 2015
`
`(c) 2014 Celgene Corporation 01/14 Us-CELG140004
`
`Page 1 of 1
`
`CFAD VI 1037 - 0001
`CFAD VI v. CELGENE
`IPR2015-01103
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
